The very limited availability of one experimental treatment for the fast-spreading Ebola virus has just as quickly raised hard questions about who should be given the medicine and under what circumstances. The issue has created hand-wringing among government officials and regulators as they sort the challenges.. And this morning, the World Health Organization released a brief outline of ethical considerations. We spoke with Robert Klitzman, an ethics expert at the Joseph Mailman School of Public Health at Columbia University, about the various dilemmas posed by the Ebola outbreak and the treatment decisions that have, so far, been made.